IRB Approval Letter

Att 15_IRB Approval Letter.pdf

Testing Act Early Messages and Materials for "Learn the Signs. Act Early" - Phase II

IRB Approval Letter

OMB: 0920-1041

Document [pdf]
Download: pdf | pdf
Date:

April 4, 2014

To:

Erika Bonilla, Project Director

From:

Kerry Levin, Chair Westat IRB

Subject:

Expedited Approval of LEARN THE SIGNS ACT EARLY, Project Number 8417.15
FWA 00005551

As Chair of the Westat Institutional Review Board (IRB), I reviewed the materials submitted for the
following: LEARN THE SIGNS ACT EARLY, Project Number 8417.15. The Westat IRB reviews all
studies involving research on human subjects. This study is funded by the Centers for Disease Control and
Prevention.
The purpose of this study is to refine development of “Learn the Signs, Act Early”, a campaign for low
income parents to identify and help children with developmental disabilities at the earliest age possible.
Westat will recruit 6 pediatric clinics in Georgia and Maryland in order to conduct the study.
Westat will conduct focus groups with parents and in-depth interviews with providers or other members of
the health care team in order to provide recommendations to existing LTSAE concepts and messages.
Further research with campaign prototypes will be evaluated during the following activities:



Focus groups and intercept interviews in clinic waiting rooms
In-depth interviews with providers

IRB regulations permit expedited review of certain activities involving minimal risk [45 CFR pt. 46.110].
This study can be considered minimal risk and is approved under expedited authority. Per [45 CFR 46
117(c)], a waiver of documentation of informed consent is also approved as the research presents no more
than minimal risk of harm to subjects and involves no procedures for which written consent is normally
required outside of the research context.
As the Project Director, you are responsible for the following:


cc:

You are required to submit this study for a continuing review on or before April 4, 2015.
In the interim, notify the IRB Office as soon as possible if there are any injuries to subjects as well
as problems or changes with the study that relate to human subjects.
Institutional Review Board
Karen Della Torre


File Typeapplication/pdf
File Modified2014-04-10
File Created2014-04-04

© 2024 OMB.report | Privacy Policy